Leonard Levin
Neuro-ophthalmology Montreal Medical Doctor
NPI 1801862941 CMS profile 671229
5252 Boul De Maisonneuve Ouest, Ste 400, Montreal H4A3S
General payments
$61,785
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Leonard Levin of Montreal is reported in the CMS Open Payments database as having received $61,785 across 16 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 93rd percentile of Neuro-ophthalmology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $34,393 | 7 | |
| 2023 | General | $650 | 1 | |
| 2022 | General | $7,313 | 1 | |
| 2021 | General | $5,495 | 1 | |
| 2020 | General | $4,906 | 1 | |
| 2019 | General | $9,028 | 5 |
Beside peers
- Leonard Levin
- Neuro-ophthalmology median
- Middle half of Neuro-ophthalmology
- National median
In program year 2025, general payments to Leonard Levin were reported at $34,393. Among 114 Neuro-ophthalmology profiles paid that year, the median was $182 and the middle half received between $62 and $718.
Show as a table
| Year | Leonard Levin | Neuro-ophthalmology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $9,028 | $337 | $122–$1,323 | $163 |
| 2020 | $4,906 | $156 | $60–$1,441 | $114 |
| 2021 | $5,495 | $278 | $121–$1,103 | $132 |
| 2022 | $7,313 | $220 | $75–$1,577 | $149 |
| 2023 | $650 | $214 | $65–$1,162 | $160 |
| 2024 | $0 | $186 | $90–$1,341 | $164 |
| 2025 | $34,393 | $182 | $62–$718 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
16 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.